Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Combining total market funds with international funds in retirement can create a diversified, tax-efficient portfolio with smoother growth.
28,507 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Solana is trading in a narrow band as a key indicator points to a potential breakout. Analysts caution that volatilit...
Three BDCs flash double-digit yields, but sustainability varies. FSK and SCM face earnings pressure and dividend cuts...
Benchmark lowered its Bakkt price target by about 47%, arguing that near-term monetization remains elusive as the com...
IonQ faces a pivotal year as government and enterprise demand grows for quantum hardware and software. Analysts outli...
The head of OURA says the CEO role is far tougher than imagined, revealing the psychological weight, team dynamics, a...
A fresh set of loan programs is rolling out as mortgage rates stay high and prices stay elevated, aiming to ease the ...
When a growth stock slips, investors scramble to understand if the fall is temporary or the start of a bigger trend. ...
Coca-Cola beat first-quarter 2026 expectations, raised guidance, and signaled margin improvement from an Africa dives...
A rising trend known as 'listing agent demands raise' is drawing scrutiny from regulators and industry groups as buye...
Grok AI foresees a sustained gold rally into late 2026 as official buyers dominate demand and the global dollar trend...
Prices are cooling in five metro areas as listings with price reductions rise. Here's what buyers and sellers should ...